In 2021, the FDA accredited ten peptide medicine, making it the most effective 12 months on record for peptide approvals, even surpassing 2017, when six peptides were accredited. The number of peptide medicine accredited has been increasing, with 21.5% of FDA-approved medication in 2022 being peptides.
